Inscripta. Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 52

Employees

  • Latest Deal Type
  • M&A

Inscripta. General Information

Description

Developer of a gene-editing technology designed to offer scalable digital genome engineering with push-button simplicity. The company's technology generates low-cost libraries of thousands of designer proteins, pathways, or genome variants, each with specifically defined and trackable mutations, enabling researchers to design, engineer, evaluate, and track results.

Contact Information

Website
www.inscripta.com
Formerly Known As
Muse Biotechnology
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5720 Stoneridge Drive
  • Suite 300
  • Pleasanton, CA 94588
  • United States
+1 (925)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Devices and Supplies
Acquirer
Manus
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 5720 Stoneridge Drive
  • Suite 300
  • Pleasanton, CA 94588
  • United States
+1 (925)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inscripta. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 15-Apr-2025 Completed Generating Revenue
10. Later Stage VC 31-May-2023 Completed Generating Revenue
9. Later Stage VC (Series E) 05-Apr-2021 Completed Generating Revenue
8. Later Stage VC (Series D) 30-Nov-2020 Completed Generating Revenue
7. Later Stage VC (Series D) 11-Nov-2019 Completed Generating Revenue
6. Later Stage VC (Series C1) 29-Mar-2019 Completed Generating Revenue
5. Later Stage VC (Series C) 28-Feb-2018 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
3. Early Stage VC (Series B) 16-Feb-2017 $23M $29M Completed Generating Revenue
2. Early Stage VC (Series A) 10-May-2016 $6.04M $6.04M Completed Startup
To view Inscripta.’s complete valuation and funding history, request access »

Inscripta. Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E
Series D
Series C1
Series C
Series B 19,784,629 $0.000010 6% $1.17 $1.17 1x $1.17 13.44%
Series A 5,157,970 $0.000010 6% $1.17 $1.17 1x $1.17 3.5%
To view Inscripta.’s complete cap table history, request access »

Inscripta. Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene-editing technology designed to offer scalable digital genome engineering with push-button simplicity
Biotechnology
Pleasanton, CA
52 As of 2025

San Diego, CA
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inscripta. Competitors (10)

One of Inscripta.’s 10 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
Mammoth Biosciences Venture Capital-Backed Brisbane, CA
Deep Genomics Venture Capital-Backed Toronto, Canada
Synthego Venture Capital-Backed Redwood City, CA
EdiGene Venture Capital-Backed Beijing, China
You’re viewing 5 of 10 competitors. Get the full list »

Inscripta. Patents

  • 567

    Total Documents Applications and Grants

  • Total Patents Families

  • 272

    Granted

  • 49

    Pending

  • Expiring in next 12 mo

Inscripta. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025207999-A2 Compositions and methods for improving carotenoid production Pending 29-Mar-2024
WO-2025207999-A3 Compositions and methods for improving carotenoid production Pending 29-Mar-2024
WO-2025075911-A1 Engineered gpp synthases Inactive 02-Oct-2023
WO-2025049431-A2 Control of flux toward 2-phenylethanol production Inactive 28-Aug-2023
WO-2025049431-A3 Control of flux toward 2-phenylethanol production Inactive 28-Aug-2023 C12N1/18
To view Inscripta.’s complete patent history, request access »

Inscripta. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inscripta. Former Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bridge Entrepreneurs Network Accelerator/Incubator
Counterpoint Global Asset Manager Minority
D1 Capital Partners Hedge Fund Minority
Durable Capital Partners Hedge Fund Minority
Fidelity Management & Research Company Asset Manager Minority
You’re viewing 5 of 25 investors. Get the full list »

Inscripta. Acquisitions (3)

Inscripta.’s most recent deal was a Merger/Acquisition with Sestina Bio. The deal was made on 18-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sestina Bio 18-Jan-2023 Merger/Acquisition Biotechnology
Infinome Biosciences 12-Dec-2022 Merger/Acquisition Biotechnology
Solana Biosciences 05-Sep-2018 Merger/Acquisition Biotechnology
To view Inscripta.’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Inscripta. FAQs

  • When was Inscripta. founded?

    Inscripta. was founded in 2015.

  • Where is Inscripta. headquartered?

    Inscripta. is headquartered in Pleasanton, CA.

  • What is the size of Inscripta.?

    Inscripta. has 52 total employees.

  • What industry is Inscripta. in?

    Inscripta.’s primary industry is Biotechnology.

  • Is Inscripta. a private or public company?

    Inscripta. is a Private company.

  • What is Inscripta.’s current revenue?

    The current revenue for Inscripta. is .

  • How much funding has Inscripta. raised over time?

    Inscripta. has raised $461M.

  • Who are Inscripta.’s investors?

    Bridge Entrepreneurs Network, Counterpoint Global, D1 Capital Partners, Durable Capital Partners, and Fidelity Management & Research Company are 5 of 25 investors who have invested in Inscripta..

  • Who are Inscripta.’s competitors?

    Illumina, Mammoth Biosciences, Deep Genomics, Synthego, and EdiGene are some of the 10 competitors of Inscripta..

  • When was Inscripta. acquired?

    Inscripta. was acquired on 15-Apr-2025.

  • Who acquired Inscripta.?

    Inscripta. was acquired by Manus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process